Improve your screening know-how with TTP LabTech at Screening Europe 2010
News Jan 28, 2010
On 11th February, TTP LabTech will be offering a free workshop entitled “The Identification of novel cancer targets using a rapid, high-content, genome wide RNAi screen”. Based on the Acumen platform, this workshop will describe how information identifying high quality hits can be accessed quickly and easily either by in-house data generation or via an outsourced service.
In addition, Gaetan Touyer, Head of Screening Group, Vitry Research Center at Sanofi Aventis will present a study of five screening assays, including cell-based protein-protein interaction, homogeneous cell receptor ligand binding and cell cycle analysis at 11.45am on the 12th February. The talk explores his experiences of integrating the Acumen eX3 microplate cytometer into an HTS platform to achieve a screening throughput of tens of thousands of wells per day using a complex yet controlled process with multiple experimental steps.
Visitors to the TTP LabTech stand #12, will also be able to find out more about the new high content screening service now on offer. Based on the industry-proven Acumen platform, this service offers a highly flexible approach to cell-based screening, providing high-throughput, content-rich and highly multiplexed data for applications such as target identification, primary screening and preclinical toxicology.
Concept Life Sciences appoints New Group Programme Manager and US Head of SalesNews
Key leadership appointments support integration of the Group and expansion in the US market.READ MORE
Blood-vessel-on-a-chip Provides Insight into Novel Anti-Inflammatory Drug CandidateNews
Researchers have discovered that synthetic APC-mimicking small molecules called “parmodulins” provide anti-inflammatory and anti-thrombotic protection to endothelial cells on par with APC’s without interfering with normal blood clotting and coagulation, making them attractive new drug candidates.READ MORE
Brian Berridge Set to Manage National Toxicology ProgramNews
The National Toxicology Program (NTP) has named Brian Berridge, D.V.M., Ph.D., as its new Associate Director. Berridge, formerly of GlaxoSmithKline, will oversee day-to-day operations as NTP coordinates toxicology research and testing across nine different federal agencies.READ MORE